TransUnion — Director's Dealing 2018

Aug 2, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransUnion (TRU)
CIK: 0001552033
Period of Report: 2018-07-30

Reporting Person: McCarthy Gerald M JR (EVP - Healthcare)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-07-30	Common Stock	M	62752	$13.06	Acquired	99390	Direct
2018-07-30	Common Stock	S	62752	$70.61	Disposed	37049	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-07-30	Stock Options (right to buy)	$13.06	M	62752	Disposed	2024-07-01	Common Stock (62752.0)	Direct

Footnotes

F1: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.38 to $70.77, inclusive. The reporting person undertakes to provide to TransUnion, any security holder of TransUnion, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: Includes 411 shares of common stock acquired pursuant to the issuer's employee stock purchase plan since the reporting person's last report.

F3: Represents an initial grant of 248,337 stock options, 40% of which vest upon the attainment of time-based vesting criteria and 60% of which vest upon the attainment of both time-based and performance-based vesting criteria. The performance-based vesting criteria was satisfied on February 22, 2017. The time-based vesting criteria is satisfied as follows: 20% on the first anniversary of the date of grant and 5% on the last day of each subsequent full calendar quarter.